Advertisement

Annals of Surgical Oncology

, Volume 26, Issue 1, pp 125–130 | Cite as

Elective Regional Therapy Treatment for Hepatic Adenoma

  • Jack P. Silva
  • Brittany Klooster
  • Susan Tsai
  • Kathleen K. Christians
  • Callisia N. Clarke
  • Harveshp Mogal
  • T. Clark GamblinEmail author
Hepatobiliary Tumors

Abstract

Background

Locoregional therapy treatments for hepatic adenoma (HA) are typically limited to selective hepatic arterial embolization (HAE) to control acute hemorrhage. This systematic review sought to report the utilization of HAE and ablation for non-emergent treatment of HA.

Methods

A PubMed query identified studies reporting ablation or embolization for HA patients. Abstracts were screened to exclude studies with only patients managed for acute hemorrhage. Outcomes of interest included rate of success, complications, and repeat procedures.

Results

Of 209 initial search results, 33 full-text publications were reviewed, and 10 were selected after applying the exclusion criteria. All were published from 2005 to 2016. A total of 105 patients were included, of which 66 patients with 138 adenomas underwent elective locoregional therapy treatment. The mean size of treated adenomas was 2.9 (range 0.8–8.3) cm. HAE was utilized in 25 patients with 58 adenomas, whereas 35 patients with 68 adenomas underwent radiofrequency ablation. Six patients with 12 adenomas received microwave ablation. Most patients were female (89/105), and adenomas were associated with oral contraceptive use or hormonal therapies in 49 of 105 patients. Success was reported in 115 of 138 first-time procedures, and repeat procedures were needed after 18 of 138. Mean follow-up time was 36.4 months, with two complications.

Conclusions

Reports of elective locoregional therapy for the treatment of HA are limited to case reports and small institutional series. In the select patients treated, outcomes are acceptable, with low rates of repeat procedures or complications. This systematic review warrants further discussion and broader consideration for the treatment of HA.

References

  1. 1.
    Thomeer MG, Broker M, Verheij J, et al. Hepatocellular adenoma: when and how to treat? Update of current evidence. Ther Adv Gastroenterol. 2016;9(6):898–912.CrossRefGoogle Scholar
  2. 2.
    Chiche L, David A, Adam R, et al. Liver transplantation for adenomatosis: European experience. Liver Transplant. 2016;22(4):516–26.CrossRefGoogle Scholar
  3. 3.
    Cho SW, Marsh JW, Steel J, et al. Surgical management of hepatocellular adenoma: take it or leave it? Ann Surg Oncol. 2008;15(10):2795–803.CrossRefGoogle Scholar
  4. 4.
    Nasser F, Affonso BB, Galastri FL, Odisio BC, Garcia RG. Minimally invasive treatment of hepatic adenoma in special cases. Einstein (Sao Paulo, Brazil). 2013;11(4):524–7.CrossRefGoogle Scholar
  5. 5.
    Erdogan D, van Delden OM, Busch OR, Gouma DJ, van Gulik TM. Selective transcatheter arterial embolization for treatment of bleeding complications or reduction of tumor mass of hepatocellular adenomas. Cardiovasc Interv Radiol. 2007;30(6):1252–8.CrossRefGoogle Scholar
  6. 6.
    Marini P, Vilgrain V, Belghiti J. Management of spontaneous rupture of liver tumours. Digestive Surg. 2002;19(2):109–13.CrossRefGoogle Scholar
  7. 7.
    Baldwin K, Katz SC, Rubin A, Somasundar P. Bipolar radiofrequency ablation of liver tumors: technical experience and interval follow-up in 22 patients with 33 ablations. J Surg Oncol. 2012;106(7):905–10.CrossRefGoogle Scholar
  8. 8.
    Rhim H, Lim HK, Kim YS, Choi D. Percutaneous radiofrequency ablation of hepatocellular adenoma: initial experience in 10 patients. J Gastroenterol Hepatol. 2008;23(8 Pt 2):e422–7.CrossRefGoogle Scholar
  9. 9.
    Yi B, Somasundar P, Espat NJ. Novel laparoscopic bipolar radiofrequency energy technology for expedited hepatic tumour ablation. HPB. 2009;11(2):135–9.CrossRefGoogle Scholar
  10. 10.
    Ahn SY, Park SY, Kweon YO, Tak WY, Bae HI, Cho SH. Successful treatment of multiple hepatocellular adenomas with percutaneous radiofrequency ablation. World J Gastroenterol. 2013;19(42):7480–6.CrossRefGoogle Scholar
  11. 11.
    Rocourt DV, Shiels WE, Hammond S, Besner GE. Contemporary management of benign hepatic adenoma using percutaneous radiofrequency ablation. J Pediatr Surg. 2006;41(6):1149–52.CrossRefGoogle Scholar
  12. 12.
    Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. J Clin Epidemiol. 2009;62(10):1006–12.CrossRefGoogle Scholar
  13. 13.
    Atwell TD, Brandhagen DJ, Charboneau JW, Nagorney DM, Callstrom MR, Farrell MA. Successful treatment of hepatocellular adenoma with percutaneous radiofrequency ablation. AJR Am J Roentgenol. 2005;184(3):828–31.CrossRefGoogle Scholar
  14. 14.
    Fujita S, Kushihata F, Herrmann GE, et al. Combined hepatic resection and radiofrequency ablation for multiple hepatic adenomas. J Gastroenterol Hepatol. 2006;21(8):1351–4.CrossRefGoogle Scholar
  15. 15.
    Kobayashi S, Sakaguchi H, Takatsuka M, et al. Two cases of hepatocellular adenomatosis treated with transcatheter arterial embolization. Hepatol Int 2009;3(2):416–20.CrossRefGoogle Scholar
  16. 16.
    Deodhar A, Brody LA, Covey AM, Brown KT, Getrajdman GI. Bland embolization in the treatment of hepatic adenomas: preliminary experience. J Vasc Interv Radiol. 2011;22(6):795–9; quiz 800.Google Scholar
  17. 17.
    van Vledder MG, van Aalten SM, Terkivatan T, de Man RA, Leertouwer T, Ijzermans JN. Safety and efficacy of radiofrequency ablation for hepatocellular adenoma. J Vasc Interv Radiol. 2011;22(6):787–93.CrossRefGoogle Scholar
  18. 18.
    Karkar AM, Tang LH, Kashikar ND, et al. Management of hepatocellular adenoma: comparison of resection, embolization and observation. HPB. 2013;15(3):235–43.CrossRefGoogle Scholar
  19. 19.
    Smolock AR, Cristescu MM, Potretzke TA, et al. Microwave ablation for the treatment of hepatic adenomas. J Vasc Interv Radiol. 2016;27(2):244–9.CrossRefGoogle Scholar
  20. 20.
    Dokmak S, Paradis V, Vilgrain V, et al. A single-center surgical experience of 122 patients with single and multiple hepatocellular adenomas. Gastroenterology. 2009;137(5):1698–705.CrossRefGoogle Scholar
  21. 21.
    Darnis B, Rode A, Mohkam K, Ducerf C, Mabrut JY. Management of bleeding liver tumors. J Visc Surg. 2014;151(5):365–75.CrossRefGoogle Scholar
  22. 22.
    Huurman VA, Schaapherder AF. Management of ruptured hepatocellular adenoma. Digest Surg. 2010;27(1):56–60.CrossRefGoogle Scholar
  23. 23.
    Stoot JH, van der Linden E, Terpstra OT, Schaapherder AF. Life-saving therapy for haemorrhaging liver adenomas using selective arterial embolization. Br J Surg. 2007;94(10):1249–53.CrossRefGoogle Scholar
  24. 24.
    van Aalten SM, Terkivatan T, van der Linden E, Verheij J, de Man RA, Ijzermans JN. Management of liver adenomatosis by radiofrequency ablation. Digest Surg. 2011;28(3):173–7.CrossRefGoogle Scholar

Copyright information

© Society of Surgical Oncology 2018

Authors and Affiliations

  • Jack P. Silva
    • 1
  • Brittany Klooster
    • 1
  • Susan Tsai
    • 1
  • Kathleen K. Christians
    • 1
  • Callisia N. Clarke
    • 1
  • Harveshp Mogal
    • 1
  • T. Clark Gamblin
    • 1
    Email author
  1. 1.Department of Surgery, Division of Surgical OncologyMedical College of WisconsinMilwaukeeUSA

Personalised recommendations